ChemBriefBeauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Major beauty firms like Galderma and L'Oreal are developing treatments for facial volume loss linked to obesity drugs like Ozempic, with the market projected to reach $2 billion within five years.
reuters · 2026-10-20 23:02 UTC